Regulatory Documents
M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
In January 2010, FDA issued this document to “recommend international standards for, and promote harmonization of, the nonclinical safety studies recommended to support human clinical...